Pharmacology S4 Flashcards
Insulin Therapy
Fast acting native insulin
Actrapid, Humulin S
Insulin Therapy
Fast acting analogues
Novorapid, Humalog
Intermediate acting native insulin (NPH)
Insulatard, Humulin I
Insulin Therapy
Intermediate / long acting analogues
Levemir, Glargine
Different Insulin Regimens
Pre-mixed insulin regimen
Humalog Mix 25, Novomix 30, Mixtard 30
◼ ◼
Taken twice daily with or before meals Lacks flexibility but only twice per day
Basal Bolus regimen features
Intermediate or long acting insulin as background Fast acting insulin with meals Flexible but up to five times per day
Side effects of insulin therapy
Hypoglycemia
Lipodystrophy
- Allergy
- Weight gain
Symptoms of hypoglycemia
Headache Vertigo Diaphoresis Shaking Inc appetite Blurred vision Weakness/ fatigue Anxiety Tachycardia Confusion
Metformin
Action?
Decreased hepatic glucose output
mitochondria
Increased glucose uptake in skeletal muscle and fat
GLUT 1 and GLUT 4
Special benefits in overweight patients
Weight-neutral or weight-reducing Improvement in cardiovascular outcomes
Metformin side effect
Side effects mitigated by slow dose titration (GI upset)
Usual maximum dose is 1g bd
Metformin contraindicated
Contraindicated in metabolic failure (renal failure, hepatic failure and acute heart failure)
Stop before radiocontrast media and surgery
Does not cause hypoglycaemia
Action of Sulphonylureas
Enhances insulin secretion (irrespective of ambient glucose level)
Specific receptor on beta cell Closure of ATP-sensitive potassium channel Influx of calcium and extrusion of secretory granules
Reduces fasting and postprandial glucose
Sulphonylureas half life
Give examples of drug with long Half life& which one is the preferred type of drug
Half-life important
Glibenclamide long half life
Can lead to prolonged hypoglycaemia, especially in elderly
Gliclazide short half-life and, therefore, preferred agent
Sulphonylureas side effect
Can cause hypoglycaemia
Associated with weight gain
Repaglinide action
Non-sulphonylurea insulin secretagogue Three receptors.
Similar action to sulphonylureas. Identical efficacy
Requires glucose to have effect
Repaglinide half life ?
Short plasma half-life
◼
0.5mg with meals, max 16 mg/day
◼
Weekly increase in dose if required
Good effect of Repaglinide
Weight neutral Less severe hypoglycaemia.
Acarbose action
a-glucosidase inhibitor
◼ ◼
Delays absorption of carbohydrates Allows beta-cell time to augment response
Decreases HbA1c by 1%, fpg by 1.5mmol/l No change in weight Modest decrease in triglyceride Dosage schedule
◼
With first bite. Start low, increase every 2 weeks.
Acarbose CI
Contraindicated in renal failure, IBD & cirrhosis
side effects of Acarbose
Rarely used owing to poor efficacy and significant GI side effects
Bloating
Constipation
Git distress